ZACHARIA ROBERTS: Open Payments
NPI 1881186385 · PAYSON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 15 payments from 10 companies in 2025. Trend: 2023 $213 · 2024 $325 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $60 |
| Teva Pharmaceuticals USA, Inc. | 2 | $50 |
| ABBVIE INC. | 2 | $36 |
| Alkermes, Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: INGREZZA, AUSTEDO XR, VRAYLAR, ARISTADA, ABILIFY ASIMTUFII, SPRAVATO, REXULTI, CAPLYTA.
Industry payments across UT — which companies pay providers there.
